The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells

Molecular and Cellular Biology

Volumn 16, Issue 4, 1996, Pages 1335-1341

  Poluha, Wojciech ^a   Poluha, Dorota K ^a   Chang, Baochong ^a   Crosbie, Nancy E ^a   Schonhoff, Christopher M ^a   Kilpatrick, Daniel L ^a   Ross, Alonzo H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CYCLIN DEPENDENT KINASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P21;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

APHIDICOLIN; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; NEUROBLASTOMA; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; PRECIPITIN TESTS; TUMOR CELLS, CULTURED;

EID: 0029916932     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.4.1335     Document Type: Article

References (68)

1. Armstrong, J. F., M. H. Kaufman, D. J. Harrison, and A. R. Clarke. 1995. High-frequency developmental abnormalities in p53-deficient mice Curr. Biol. 5:931-936.
2. Baker, D. L., U. R. Reddy, D. Pleasure, C. L. Thorpe, A. E. Evans, P. S. Cohen, and A. H. Ross. 1989 Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines Cancer Res. 49:4142-4146.
3. Biedler, J. L., S. R. Tarlow, M. Schachner, and L. S. Freedman. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:3751-3757.
4. Borner, M. M., C. E. Meyers, O. Sartor, Y. Sei, T. Toko, J. B. Trepel, and E. Schneider. 1995. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 55:2122-2128.
5. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (London) 377:552-557.
6. Buchkovich, K. J., and E. B. Ziff. 1994. Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells. Mol. Biol. Cell 5:1225-1241.
7. Canman, C. E., T. M. Gilmer, S. B. Coutts, and M. B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:600-611
8. Chen, J., B. Chattopadhyay, G. Venkalakrishnan, and A. H. Ross. 1990. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ. 1:79-85.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Davidoff, A. M., J. C. Pence, N. A. Shorter, J. D. Iglehart, and J. R. Marks. 1992. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 7:127-133.
11. CIP1/WAF1 undergo normal development but are defective in G1 checkpoint control. Cell 82:675-684.
12. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel, and A. Bradley. 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (London) 356:215-221.
13. Donovan, M. J., B. L. Hempstead, C. Horvath, M. V. Chao, and D. Schofield. 1993. Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am. J. Pathol. 143:1560-1567.
14. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
15. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, J. D. Iglehart, and J. R. Marks. 1994. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301-1307.
16. El-Deiry, W., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
17. 1 arrest and apoptosis. Cancer Res. 54:1169-1174.
18. Freeman, R. S., S. Estus, and E. M. Johnson. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355.
19. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311:433-438.
20. Gregory, C. D., C. Dive, S. Henderson, C. A. Smith, G. T. Williams, J. Gordon, and A. B. Rickinson. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (London) 349:612-614
21. Gunning, P., P. Ponte, H. Okayama, J. Engel, H. Blau, and L. Kedes. 1983. Isolation and characterization of full-length cDNA clones for human α- β-, and γ-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed Mol. Cell. Biol. 3:787-795.
22. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
23. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
24. Hayes, T. E., N. L. M. Valtz, and R. D. G. McKay. 1991 Downregulation of cdc2 upon terminal differentiation of neurons. New Biol. 3:259-269.
25. Jensen, L. M. 1987. Phenotypic differentiation of aphidicolin-selected human neuroblastoma cultures after long-term exposure to nerve growth factor. Dev. Biol 120:56-64
26. Jiang, H., J. Lin, Z.-Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21. WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406.
27. Khanna, K. K., and M. F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8:3307-3312.
28. Knudson, A. G., and A. T. Meadows. 1980. Regression of neuroblastoma IV-S: a genetic hypothesis N. Engl. J. Med. 302:1254-1256.
29. Kogner, P., G. Barbany, C. Dominici, M. A. Castello, G. Raschella, and H. Persson. 1993. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044-2050.
30. Komuro, H., Y. Hayashi, M. Kawamura, K. Hayashi, Y. Kaneko, S. Kamoshita, R. Hanada, K. Yamamoto, T. Hongo, M. Yamada, and Y. Tsuchida. 1993. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res. 53:5284-5288.
31. Krek, W., and E. A. Nigg. 1989. Structure and developmental expression of the chicken CDC2 kinase EMBO J. 8:3071-3078.
32. Lin, J., X. Wu, J. Chen, A. Chang, and A. J. Levine. 1995. Functions of the p53 protein in growth regulation and tumor suppression Cold Spring Harbor Symp. Quant. Biol. 59:215-223.
33. LoPresti, P., W. Poluha, D. K. Poluha, E. Drinkwater, and A. H. Ross. 1992. Neuronal differentiation triggered by blocking cell proliferation Cell Growth Differ. 3:627-635.
34. Matthews, J. A., A. Batki, C. Hynds, and L. J. Kricka. 1985. Enhanced chemiluminescent method for the detection of DNA dot-hybridization assays. Anal. Biochem. 151:205-209.
35. Meikrantz, W., S. Gisselbrecht, S. W. Tam, and R. Schlegel. 1994. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA 91:3754-3758.
36. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
37. Miyajima, M., H. O. Nornes, and T. Neuman. 1995. Cyclin E is expressed in neurons and forms complexes with cdk5. NeuroReport 6:1130-1132.
38. Moll, U. M., M. LaQuaglia, J. Benard, and G. Riou. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92:4407-4411.
39. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
40. Murray, A., and T. Hunt. 1993. The cell cycle. W. H Freeman, New York.
41. Nakagawara, A., M. Arima-Nakagawara, N. J. Scavard, C. G. Azar, A. B. Cantor, and G. M. Brodeur. 1993. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328:847-854.
42. Nakanishi, M., G. R. Adami, R. S. Robetorye, A. Noda, S. F. Venable, D. Dimitrov, O. M. Pereira-Smith, and J. R. Smith. 1995. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl Acad. Sci. USA 92:4352-4356
43. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
44. Oberhammer, F., J. W. Wilson, C. Dive, I. D. Morris, J. A. Hickman, A. E. Wakeling, P. R. Walker, and M. Sikorska. 1993. Apoptotic death in epithelial cells, cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:3679-3684.
45. 3H-thymidine incorporation and neurogenesis. J. Neurosci. 13:2930-2938.
46. Ormerod, M. G., C. F. O'Neill, D. Robertson, and K. R. Harrap. 1994. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res. 211:231-237.
47. Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olson, J. W. Harper, and S. J. Elledge. 1995. p53-independent expression of p21 Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
48. Poluha, W., D. K. Poluha, and A. H. Ross. 1995. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 10:185-189.
49. Quattrone, A., G. Di Pasquale, and S. Capaccioli. 1995. Enhancing antisense oligonucleotide intracellular levels by means of cationic lipids as vectors. Biochemica 1:25-29.
50. Rudkin, B. B., P. Lazarovici, B.-Z. Levi, Y. Abe, K. Fujita, and G. Guroff. 1989. Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation. EMBO J. 8:3319-3325.
51. Schwartz, L. M., S. W. Smith, M. E. E. Jones, and B. A. Osborne. 1993. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA 90:980-984.
52. Sheikh, M. S., X.-S. Li, J.-C. Chen, Z.-M. Shao, J. V. Ordonez, and J. A. Fontana. 1994 Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415.
53. Shi, L., W. K. Nishioka, J. Th'ng, E. M. Bradbury, D. W. Litchfield, and A. H. Greenberg. 1994. Premature p34cdc2 activation required for apoptosis. Science 263:1143-1145.
54. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024
55. Sonnenfeld, K. H., and D. H. Ishii. 1982. Nerve growth factor effects and receptors in cultured human neuroblastoma cell lines J. Neurosci. Res. 8:375-391.
56. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. El-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
57. Suzuki, T., E. Bogenmann, H. Shimada, D. Stram, and R. C. Seeger. 1993. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl. Cancer Inst 85:377-384.
58. Tamaru, T., M. Okada, and H. Nakagawa. 1994. Differential expression of D type cyclins during neuronal maturation. Neurosci. Lett. 168:229-232.
59. Tsai, L.-H., T. Takahashi, V. S. Caviness, and E. Harlow. 1993. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040.
60. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. 1985 Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene Nucleic Acids Res. 13:2485-2502.
61. Verdi, J. M., and D. J. Anderson. 1994 Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts. Neuron 13:1359-1372.
62. Vogan, K., M. Bernstein, J.-M. Leclerc, L. Brisson, J. Brossar, G. M. Brodeur, J. Pelletier, and P. Gros. 1993. Absence of p53 mutations in primary neuroblastomas. Cancer Res. 53:5269-5273.
63. Vogel, K. S., C. I. Brannan, N. A. Jenkins, N. G. Copeland, and L. F. Parada. 1995. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-742.
64. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
65. Wagner, R. W. 1994. Gene inhibition using antisense oligodeoxynucleotides. Nature (London) 372:333-335.
66. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
67. Van, G.-Z., and E. B. Ziff. 1995. NGF regulates the PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1 J. Neurosci. 15:6200-6212
68. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.